TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15388005

Group type: EXPERIMENTAL
Intervention: Toremifene plus MVP chemotherapy (mitomycin, vindesin, and cisplatin)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control arm (MVP chemotherapy only)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Pre-treatment arm (previously treated with chemotherapy)
Number of subjects: 63
Study: 11399102

Group type: EXPERIMENTAL
Intervention: Hyaluronan (Hyalgan), 20 mg/2 ml once a week for 5 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methylprednisolone (Depo‐Medrol, 40 mg/1 ml once a week for 3 weeks)
Number of subjects: 24
Study: 9416723

Group type: EXPERIMENTAL
Intervention: Aprotinin (total dose, 6 x 10(6) kallikrein inactivator units)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Epsilon-aminocaproic acid (total dose, 270 mg/kg)
Number of subjects: 204
Study: 8495761

Group type: EXPERIMENTAL
Intervention: Superovulation with adjunctive leuprolide acetate (LA) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Superovulation without adjunctive leuprolide acetate (LA) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Threshold P concentrations proposed in other studies
Number of subjects: 0
Study: 3122065

Group type: EXPERIMENTAL
Intervention: Exercise 3 times weekly for 1 month
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise 7 times weekly for 1 month
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise 3 times weekly for 1 year
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise 3 times weekly after cessation of long-term drug therapy
Number of subjects: 25
Study: 31701861

Group type: EXPERIMENTAL
Intervention: Hand sanitizer and respiratory hygiene education
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 24
Study: 29976277

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg once daily for 1 week followed by 20 mg once daily (intensive treatment group, IT group, n=49)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg once daily (standard treatment group, ST group, n=54)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg once daily for 1 week followed by 20 mg once daily (intensive treatment group, IT group)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg once daily (standard treatment group, ST group)
Number of subjects: 103
Study: 26988432

Group type: COMPARATOR
Intervention: 14% Plai cream
Number of subjects: 75

Group type: COMPARATOR
Intervention: 7% Plai cream
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 75
Study: 23846158

Group type: EXPERIMENTAL
Intervention: HCE (exercise group, n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: HCS (control group, n = 6)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 22082345

Group type: EXPERIMENTAL
Intervention: Coping Strategies Scale (CSS)
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Brief versions of the CSS
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: CSS and brief versions of CSS
Number of subjects: 751
Study: 19460131

Group type: EXPERIMENTAL
Intervention: Real transcranial magnetic stimulation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham transcranial magnetic stimulation
Number of subjects: 28
Study: 17314580

Group type: EXPERIMENTAL
Intervention: Glucose plus sucking (A)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SS performed by nurses (B)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SS performed by mothers (C)
Number of subjects: 66
Study: 16271099

Group type: EXPERIMENTAL
Intervention: S-303-treated RBCs
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control RBCs
Number of subjects: 223
Study: 12136225

Group type: EXPERIMENTAL
Intervention: Informational intervention (specific, objective information about radiation treatments)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Comparison group (general information)
Number of subjects: 152
Study: 9836030

Group type: EXPERIMENTAL
Intervention: Standardized tutorial regarding PCA use (20 min)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No additional education apart from routine preoperative anaesthetic consultation
Number of subjects: 85
Study: 8133537

Group type: EXPERIMENTAL
Intervention: Topically applied all-trans-retinoic acid (RA) 0.372%
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 2683543

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral blockade with bupivacaine 0.5% (15 ml followed by 5 ml/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thoracic epidural blockade with bupivacaine 7 ml 0.5% + morphine 2 mg followed by 5 ml/h + 0.2 mg/h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 1137478

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise plus biofeedback training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Therapeutic exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 20
Study: 31888788

Group type: EXPERIMENTAL
Intervention: Chinese Children's Asthma Action Plan (CCAAP) instructions
Number of subjects: 173

Group type: COMPARATOR
Intervention: Usual asthma care
Number of subjects: 173
Study: 29785889

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation at 0.5 g/kg feed
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation at 1.0 g/kg feed
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation at 2.0 g/kg feed
Number of subjects: 96
Study: 28106308

Group type: EXPERIMENTAL
Intervention: Placebo hypoalgesia (green cue)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nocebo hyperalgesia (red cue)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CNV mean amplitude (early component)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CNV mean amplitude (late component)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reaction time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 2 (no conditioning)
Number of subjects: 0
Study: 24119149

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 IU) administered orally every week for 8 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo administered orally every week for 8 weeks
Number of subjects: 53
Study: 22930072

Group type: EXPERIMENTAL
Intervention: Defatted flaxseed
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Whole flaxseed
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Defatted flaxseed and placebo muffins
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Whole flaxseed and defatted flaxseed
Number of subjects: 18
Study: 22026529

Group type: EXPERIMENTAL
Intervention: Genuine auricular therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham auricular therapy (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (genuine auricular therapy and sham)
Number of subjects: 0
Study: 19187286

Group type: EXPERIMENTAL
Intervention: Albiglutide (0.25 + 1 mg, 3 + 6 mg, 16 + 24 mg, 48 + 60 mg, 80 + 104 mg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 17519067

Group type: EXPERIMENTAL
Intervention: Ramelteon 4 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 15382776

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer luting cement (Vitremer)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Zinc phosphate luting cement
Number of subjects: 20
Study: 16280089

Group type: EXPERIMENTAL
Intervention: NSAIDs and/or SMT in addition to general practitioner advice and paracetamol
Number of subjects: 240
Study: 10326923

Group type: EXPERIMENTAL
Intervention: Dynamic wheelchair cushion (upright position)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gel cushion (tilted position)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dry-flotation cushion (tilted position)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gel cushion (upright position)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dry-flotation cushion (upright position)
Number of subjects: 16
Study: 8566580

Group type: EXPERIMENTAL
Intervention: Intracolonic injection of glycerol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrarectal injection of glycerol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine (administered prior to glycerol injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paraffin oil (control for glycerol injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Octreotide and granisetron (drugs acting on visceral afferent pathways)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phloroglucinol (spasmolytic drug)
Number of subjects: 0
Study: 2019798

Group type: EXPERIMENTAL
Intervention: Mini Shah grommet
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional Shah grommet
Number of subjects: 116
Study: 7184471

Group type: EXPERIMENTAL
Intervention: Topical tuberculin jelly (14 patients)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Yellow petrolatum (7 patients)
Number of subjects: 21
Study: 29713891

Group type: EXPERIMENTAL
Intervention: Technique 1 group (T1) - one shade tissues, B1B
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Technique 2 group (T2) - two-shades tissues, A2Dentin and B1Enamel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Technique 3 group (T3) - three shade tissues, A2Dentin, Transparent, and B1Enamel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Positive Control Group - dental tissues with enamel, dento-enamel junction DEJ, and dentin
Number of subjects: 20
Study: 28643207

Group type: EXPERIMENTAL
Intervention: Children of parents with less severe depression (n=19)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Children of parents with more severe depression (n=12)
Number of subjects: 31
Study: 26414696

Group type: EXPERIMENTAL
Intervention: Forced-rate exercise (FE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Voluntary-rate exercise (VE)
Number of subjects: 27
Study: 24378206

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study: 22980299

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 18610

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 18610
Study: 20178036

Group type: EXPERIMENTAL
Intervention: Cultural priming with individualism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultural priming with collectivism
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (unfamiliar person)
Number of subjects: 0
Study: 17572422

Group type: EXPERIMENTAL
Intervention: Micronized 17beta‐estradiol 1 mg plus dydrogesterone 10 mg sequential added (LD‐HT; group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dydrogesterone 10 mg from day 15 to 28 (group B)
Number of subjects: 120
Study: 16153515

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) examinations performed by trained physicians
Number of subjects: 10000
Study: 11845759

Group type: EXPERIMENTAL
Intervention: Washable pants with integral pads
Number of subjects: 72
Study: 10217391

Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Willingness to pay (WTP) for reductions in febrile neutropenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Willingness to pay (WTP) for reductions in neurotoxicity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Willingness to pay (WTP) for reductions in nephrotoxicity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amifostine (base case analysis)
Number of subjects: 0
Study: 8824737

Group type: EXPERIMENTAL
Intervention: Sunder Vati
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Other Ayurvedic formulations
Number of subjects: 82
Study: 30686952

Group type: EXPERIMENTAL
Intervention: GC1107 (adult tetanus diphtheria vaccine)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control vaccine (Td vaccine)
Number of subjects: 253
Study: 28892121

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 7213

Group type: EXPERIMENTAL
Intervention: Statin users with elevated total cholesterol
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Non-users with elevated total cholesterol
Number of subjects: 7213
Study: 25608632

Group type: EXPERIMENTAL
Intervention: Flurbiprofen Axetil (FA) with fentanyl in postoperative controlled intravenous analgesia (PCIA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 23592107

Group type: EXPERIMENTAL
Intervention: Shock wave + BMCs
Number of subjects: 103

Group type: COMPARATOR
Intervention: Shock wave + placebo infusion
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo shock wave + BMCs
Number of subjects: 103
Study: 22104320

Group type: EXPERIMENTAL
Intervention: ½ cup of pinto beans for 8 weeks (Study 1)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: ½ cup of black-eyed peas for 8 weeks (Study 1)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: ½ cup of baked beans for 8 weeks (Study 2)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (canned carrots) for 8 weeks (Study 1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (canned carrots) for 8 weeks (Study 2)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: ½ cup of pinto beans for 12 weeks (Study 3)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control soup for 12 weeks (Study 3)
Number of subjects: 86
Study: 19419845

Group type: EXPERIMENTAL
Intervention: Fluoxetine + Pindolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoxetine + Placebo
Number of subjects: 0
Study: 16684688

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (Ventoline Diskhaler) 200 microg three times a day
Number of subjects: 15

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 15
Study: 15461065

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 643
Study: 11736858

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: (+)-chlorpheniramine 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: (+)-chlorpheniramine 6 mg
Number of subjects: 0
Study: 9246150

Group type: EXPERIMENTAL
Intervention: Single i.v. dolasetron dose (0.6 mg/kg) before cisplatin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Multiple i.v. dose regimen (0.6 mg/kg x 3) given before and after cisplatin
Number of subjects: 30
Study: 7975420

Group type: EXPERIMENTAL
Intervention: Apple powder
Number of subjects: 38
Study: 3442398

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Treadmill plus isometric exercise
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Treadmill test
Number of subjects: 17
Study: 31160146

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day for four days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (for four days)
Number of subjects: 41
Study: 28851462

Group type: EXPERIMENTAL
Intervention: Pedometer-based behavior-change intervention during inpatient pulmonary rehabilitation
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group (standard pulmonary rehabilitation without the pedometer-based intervention)
Number of subjects: 502
Study: 25958096

Group type: EXPERIMENTAL
Intervention: Vomer flap (VF) protocol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Two-flap technique (TF) protocol
Number of subjects: 200
Study: 23379397

Group type: EXPERIMENTAL
Intervention: Novel education intervention (n = 40)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional code blue and rapid response education (Control group, n = 39)
Number of subjects: 79
Study: 21591241

Group type: COMPARATOR
Intervention: Low Protein / High Glycemic Index diet
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: High Protein / Low Glycemic Index diet
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index diets (high or low protein content)
Number of subjects: 548
Study: 19696637

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal (prednisone) for 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Triple therapy (prednisone, cyclosporine, and mycophenolate)
Number of subjects: 32
Study: 16877210

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted wound closure (VAC) technique
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional wet dressing technique (CWD)
Number of subjects: 24
Study: 12921212

Group type: EXPERIMENTAL
Intervention: Desistors
Number of subjects: 80

Group type: COMPARATOR
Intervention: Persistors
Number of subjects: 80
Study: 10710839

Group type: EXPERIMENTAL
Intervention: Psychotherapy homework compliance
Number of subjects: 0
Study: 9200166

Group type: EXPERIMENTAL
Intervention: Long wavelength pass filters dispensed as tinted spectacles
Number of subjects: 0
Study: 8259034

Group type: EXPERIMENTAL
Intervention: Total therapeutic paracentesis (TTP) plus i.v. albumin (5 g/l of fluid)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Total therapeutic paracentesis (TTP) without albumin
Number of subjects: 35
Study: 3519644

Group type: EXPERIMENTAL
Intervention: Bromocriptine (1.25 mg twice daily, increased to 2.5 mg twice daily if no improvement)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Both groups (Bromocriptine and Placebo)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg/day)
Number of subjects: 55
Study: 29439359

Group type: EXPERIMENTAL
Intervention: LF-HF rTMS (1 Hz to the contralesional hemisphere followed by 10 Hz to the lesional hemisphere)
Number of subjects: 62

Group type: COMPARATOR
Intervention: LF-rTMS (1 Hz to the contralesional hemisphere)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 62
Study: 28688525

Group type: EXPERIMENTAL
Intervention: FDG-guided dose-escalation (mean doses of 95Gy for tumour and 74Gy for lymph nodes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment (66Gy/33F plans)
Number of subjects: 30
Study: 25714724

Group type: EXPERIMENTAL
Intervention: A standardized extract from Ageratina pichinchensis (5 %, cream formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Micronized silver sulfadiazine (1 %)
Number of subjects: 0
Study: 22836585

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 70 mg/week in addition to TPTD
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Raloxifene (RAL) 60 mg/d in addition to TPTD
Number of subjects: 125

Group type: COMPARATOR
Intervention: TPTD monotherapy (no additional medication)
Number of subjects: 125
Study: 21729676

Group type: EXPERIMENTAL
Intervention: FUFIRI (5-fluorouracil [5-FU], leucovorin, irinotecan)
Number of subjects: 479

Group type: COMPARATOR
Intervention: mIROX (modified irinotecan plus oxaliplatin)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 479
Study: 19148787

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-NSAID users
Number of subjects: 0
Study: 16464979

Group type: EXPERIMENTAL
Intervention: Subacromial ropivacaine 0.2% (Group R)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Subacromial fentanyl 4 microg ml(‐1) (Group F)
Number of subjects: 48

Group type: COMPARATOR
Intervention: i.v. fentanyl 4 microg ml(‐1) (Group C)
Number of subjects: 48
Study: 15142198

Group type: EXPERIMENTAL
Intervention: Asacol (800 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Balsalazide (2250 mg)
Number of subjects: 19
Study: 11463965

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study: 9762783

Group type: EXPERIMENTAL
Intervention: formoterol dry powder 24 microg twice daily (08:00 and 20:00 h)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: formoterol 24 microg once daily (20:00 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 7527922

Group type: EXPERIMENTAL
Intervention: VLAP (Vaporization of the Prostate using Laser Ablation Procedure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TURP (Transurethral Resection of the Prostate)
Number of subjects: 0
Study: 2500692

Group type: EXPERIMENTAL
Intervention: Naaga (the magnesium salt of N‐acetyl‐aspartyl‐glutamate)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Disodium cromoglycate
Number of subjects: 100
Study: 31842191

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 20
Study: 28349504

Group type: EXPERIMENTAL
Intervention: 1.25 mg intravitreal bevacizumab (IVB) injection
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combination of 1.25 mg IVB and 1 mg intravitreal triamcinolone (IVT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Combination of 1.25 mg IVB and 1 mg IVT
Number of subjects: 46
Study: 26944026

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 510

Group type: COMPARATOR
Intervention: Atosiban
Number of subjects: 510
Study: 24288260

Group type: EXPERIMENTAL
Intervention: Amide proton transfer (APT) MRI
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control white matter APT values
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: APT signal in final infarct region
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: APT imaging
Number of subjects: 10
Study: 24251742

Group type: EXPERIMENTAL
Intervention: Stronger group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Weaker group
Number of subjects: 24
Study: 21312288

Group type: EXPERIMENTAL
Intervention: Vehicle plus 75 g of glucose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vehicle plus 75 mg of caffeine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vehicle plus 75 g of glucose and 75 mg of caffeine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle (water, 150 ml)
Number of subjects: 40